Risk of lower extremity amputations in people with type 2 diabetes mellitus treated with sodium‐glucose co‐transporter‐2 inhibitors in the USA: A retrospective cohort study

AIMS: To examine the incidence of amputation in patients with type 2 diabetes mellitus (T2DM) treated with sodium glucose co‐transporter 2 (SGLT2) inhibitors overall, and canagliflozin specifically, compared with non‐SGLT2 inhibitor antihyperglycaemic agents (AHAs). MATERIALS AND METHODS: Patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Zhong, DeFalco, Frank J., Ryan, Patrick B., Schuemie, Martijn J., Stang, Paul E., Berlin, Jesse A., Desai, Mehul, Rosenthal, Norm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836890/
https://www.ncbi.nlm.nih.gov/pubmed/28898514
http://dx.doi.org/10.1111/dom.13115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836890/
https://www.ncbi.nlm.nih.gov/pubmed/28898514
http://dx.doi.org/10.1111/dom.13115

Ejemplares similares